Abstract
A rapid and simple analytical capillary zone electrophoresis (CZE) method has been developed and validated for quantitative determination of atypical antipsychotic drug risperidone in commercially available film-coated tablets. CZE was performed in an uncoated fused-silica capillary 40.2 cm total length x 75 µm i.d. (30 cm effective length) using a 20 mmol mL-1 sodium phosphate solution containing 0.1% triethylamine (v/v), pH 2.5 adjusted with ortho-phosphoric acid as background electrolyte. The applied voltage was +28 kV and UV detection at 236 nm, nitrazepam was used as internal standard (IS). Under these conditions, the separation of risperidone was achieved in less than 2.5 min. The method was validated and response was found to be linear with determination coefficient better than 0.999. The repeatability and intermediate precision expressed as relative standard deviation were less than 1.5 %. The accuracy, resulting from recovery experiments, was between 98.84 and 101.24 %. The active pharmaceutical ingredient was subjected to acid, alkaline and neutral hydrolysis and oxidative stress conditions. No interference from degradation products and also from tablet excipients was observed. The method was simple, precise and fast and could be successfully applied for determination of risperidone in pharmaceutical dosage forms and can be used for routine analysis in pharmaceutical industries. Furthermore, the method can be used as a stability-indicating method.
Keywords: Capillary zone electrophoresis, method validation, neuroleptic drug, pharmaceuticals, quantitative determination, risperidone.
Current Analytical Chemistry
Title:Development and Validation of a Capillary Zone Electrophoresis Method for the Quantitative Determination of Atypical Antipsychotic Risperidone in Pharmaceutical Dosage forms
Volume: 10 Issue: 2
Author(s): Fernanda N.I. Nagase, Aline E. Asato, Pedro López Garcia, Angel A. Gaona Galdos, Maria Ines R.M. Santoro, Erika R.M. Kedor-Hackmann and María Segunda Aurora-Prado
Affiliation:
Keywords: Capillary zone electrophoresis, method validation, neuroleptic drug, pharmaceuticals, quantitative determination, risperidone.
Abstract: A rapid and simple analytical capillary zone electrophoresis (CZE) method has been developed and validated for quantitative determination of atypical antipsychotic drug risperidone in commercially available film-coated tablets. CZE was performed in an uncoated fused-silica capillary 40.2 cm total length x 75 µm i.d. (30 cm effective length) using a 20 mmol mL-1 sodium phosphate solution containing 0.1% triethylamine (v/v), pH 2.5 adjusted with ortho-phosphoric acid as background electrolyte. The applied voltage was +28 kV and UV detection at 236 nm, nitrazepam was used as internal standard (IS). Under these conditions, the separation of risperidone was achieved in less than 2.5 min. The method was validated and response was found to be linear with determination coefficient better than 0.999. The repeatability and intermediate precision expressed as relative standard deviation were less than 1.5 %. The accuracy, resulting from recovery experiments, was between 98.84 and 101.24 %. The active pharmaceutical ingredient was subjected to acid, alkaline and neutral hydrolysis and oxidative stress conditions. No interference from degradation products and also from tablet excipients was observed. The method was simple, precise and fast and could be successfully applied for determination of risperidone in pharmaceutical dosage forms and can be used for routine analysis in pharmaceutical industries. Furthermore, the method can be used as a stability-indicating method.
Export Options
About this article
Cite this article as:
Nagase N.I. Fernanda, Asato E. Aline, Garcia López Pedro, Galdos A. Gaona Angel, Santoro Ines R.M. Maria, Kedor-Hackmann R.M. Erika and Aurora-Prado Segunda María, Development and Validation of a Capillary Zone Electrophoresis Method for the Quantitative Determination of Atypical Antipsychotic Risperidone in Pharmaceutical Dosage forms, Current Analytical Chemistry 2014; 10 (2) . https://dx.doi.org/10.2174/15734110113099990029
DOI https://dx.doi.org/10.2174/15734110113099990029 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Advances in Microfluidic and Sensing Technologies of Biofluids.
Detection of biological fluids is an important means to assess human health and diagnose diseases. Currently, research on blood is relatively mature and widely applied in the medical field. With the development and advancement of microfluidic technology and novel detection methods, attention has turned to human physiological fluids such as ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Infectious Agents and Neurodegenerative Diseases: Exploring the Links
Current Topics in Medicinal Chemistry Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders
Current Alzheimer Research Transient Cerebral Ischemia Leads to TGF-β2 Expression in Golgi Apparatus Organelles
Current Neurovascular Research Tau in Alzheimer Disease and Related Tauopathies
Current Alzheimer Research Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
Current Alzheimer Research In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Recent Patents on CNS Drug Discovery (Discontinued) Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology Second Generation Antipsychotics in Asperger’s Disorder and High Functioning Autism: A Systematic Review of the Literature and Effectiveness of Meta-Analysis.
Current Clinical Pharmacology ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Current Topics in Medicinal Chemistry Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design Locus (Coeruleus) Minoris Resistentiae in Pathogenesis of Alzheimer’s Disease
Current Alzheimer Research Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Modulation and Detection of Tau Aggregation with Small-Molecule Ligands
Current Alzheimer Research Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic
Current Medicinal Chemistry Postnatal Brain Development and Psychotropic Drugs. Effects on Animals and Animal Models of Depression and Attention-Deficit/Hyperactivity Disorder
Current Pharmaceutical Design Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
Current Pharmaceutical Design Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
Current Drug Targets